CannaPhytica is firmly at the center of the German Cannabis Industry, with an unmatched history of research, analytical data and understanding of both the current market and pharmaceutical industry.

Our R&D centre based in Sanitz is licensed to deal with the manufacture of THC. Through its expertise in science and regulation, we are able to deliver THC in natural and synthetic forms covering an umbrella of regulated and approved fields such as, the pharmaceutical industry, cosmetic industry and food industry.

Our different grades of THC go through stringent regulatory and compliance controls following cGMP guidelines before being released to market. Cannaphytica aims to be the pioneer in the European THC market and is also now focusing on researching new molecules of interest surrounding this scaffold to aim for the API market.